Project Grant R01ES038296
- The National Institute for Minority Health and Health Disparities awarded the University of Hawaii at Manoa $757,593 on September 1, 2026, under the Minority Health and Health Disparities Research program (CFDA 93.307) to conduct the Maui Wildfire Exposure Study - Children's Cohort (MAUIWES-CHILDREN), investigating the long-term health, developmental, and educational impacts of the August 8, 2023, Maui wildfires on children. The study expands an existing cohort by enrolling 400...
- The National Institute of Environmental Health Sciences, part of the Department of Health and Human Services, awarded $465,667 to the University of California, Los Angeles on July 1, 2026, under the Environmental Health grant program (CFDA 93.113). The award funds epidemiological research examining how pregnant women and those at conception exposed to the January 2025 Los Angeles wildfires (Pacific Palisades and Altadena fires) adopted and responded to risk mitigation strategies. The research...
- The National Institute of Environmental Health Sciences awarded the University of Hawaii $156,500 on April 9, 2026, under the Environmental Health program (CFDA 93.113) to establish and validate new approach methodologies (NAMs) for developmental and reproductive toxicity assessment using pluripotent stem cell–derived morphogenesis models. The award funds development of validated in vitro screening tools to replace animal testing in pharmaceutical safety assessment. The recipient's laboratory...
- The National Institute of Environmental Health Sciences awarded the University of California, Los Angeles $354,375 on April 3, 2026, under the Environmental Health program (CFDA 93.113) to assess indoor and outdoor exposure to fine and ultrafine particles and volatile organic compounds in Los Angeles-area homes affected by the January 2025 Palisades and Eaton wildfires. The recipient is monitoring air quality across 50 households (25 near each fire) to characterize post-fire exposure pathways,...
- The National Institute of Environmental Health Sciences awarded the University of Southern California $884,126 on September 19, 2025, under the Environmental Health program (CFDA 93.113) to investigate biological signatures of prenatal wildfire smoke exposure and fetal and infant growth. The recipient will examine extracellular vesicles and microRNAs as biomarkers of wildfire smoke exposure in pregnancy and their association with adverse birth outcomes. The study enrolls 466 participants from...
- The National Institute of Environmental Health Sciences awarded $818,402 to The Trustees of Columbia University in the City of New York on July 2, 2026, under the Environmental Health program (CFDA 93.113) to investigate the association between polycyclic aromatic hydrocarbon (PAH) exposure during reproductive windows of susceptibility and biomarkers of chronic disease risk in midlife women. The research leverages the Columbia Center for Children's Environmental Health Mothers and Newborns...
- The National Institute of Environmental Health Sciences awarded $722,000 to the President and Fellows of Harvard College (Harvard T.H. Chan School of Public Health) on August 26, 2026, under the Environmental Health program (CFDA 93.113) to develop an integrated molecular exposomics platform mapping how environmental chemicals move from blood to tissues and alter cellular function. The project establishes three synergistic modules. Module 1 creates comprehensive blood exposomics using...
- The National Institute of Environmental Health Sciences awarded $758,827 to the University of California, Merced on July 10, 2026, under the Environmental Health program (CFDA 93.113) for research on wildfire smoke exposure, health effects, and mitigation solutions. The project studies the effects of wildfire particulate matter (PM2.5) on pregnant people and newborns in California, with particular focus on how maternal exposure to wildfire smoke affects adverse pregnancy and infant outcomes. The...
- The Department of Agriculture National Institute of Food and Agriculture awarded the University of Hawaii at Manoa $490,916 on September 15, 2026, under the Alaska Native Serving and Native Hawaiian Serving Institutions Education Grants program (CFDA 10.228) to assess contaminant levels in West Maui coastal waters and reef fish and their food safety implications. The project will synthesize existing data on coastal water quality and coral reef ecosystem health with new measurements of...
- Federal Project Grant Award Summary The National Institute of Environmental Health Sciences (NIEHS) awarded UCLA a $409,687 Project Grant (CFDA 93.113, Environmental Health program) on June 24, 2025, with completion targeted for June 13, 2027. This research initiative delivers a comprehensive epidemiological investigation examining the impacts of wildfire smoke and heat exposure on cognitive decline, mood disorders, and metabolic changes in older adults with Parkinson's Disease (PD)....
The National Institute of Environmental Health Sciences awarded the University of Hawaii at Manoa a Project Grant of $726,917 on August 19, 2026, under the Environmental Health program (CFDA 93.113) to establish the Health and Environment Assessment Longitudinal (HEAL) cohort, a community-engaged longitudinal study investigating how legacy pollutant exposure from Hawaii's historic sugarcane industry—including heavy metals, dioxins, and arsenic-treated construction materials—independently and in combination with wildfire exposure affects cardiopulmonary health. Over five years, the study will recruit 1,000 participants across four exposure groups: unexposed controls (200); legacy-pollutant-exposed residents near abandoned sugarcane plantations without wildfire exposure (300); wildfire-exposed individuals without legacy pollutant exposure (200); and individuals with both exposures (300), including survivors of the 2023 Maui wildfires returning to Lahaina, Kula, Kihei, and Olinda. The HEAL cohort integrates citizen science, environmental sampling, biomarker analyses, and geospatial modeling to examine independent and combined cardiopulmonary disease risks from both exposure pathways. Place of performance is Honolulu, Hawaii, with a period of performance ending May 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $726.9k | 8/19/26 |